Blood

Vol. 146, Issue Supplement 1 Issue Supplement 1 2025
8248
Articles

Articles in this Issue

Rising mortality trends in elderly multiple myeloma patients with hypertension: A CDC wonder database analysis (1999–2023)

Rehan Ishaque, Zauha Fawad Memon, Abdul basit Khan et al. Nov 03, 2025 pp. 2793-2793 10.1182/blood-2025-2793

Abstract INTRODUCTION Multiple Myeloma (MM) is the second most fatal hematological malignancy after Acute Myeloid Leukemia (AML) and inciden...

Ex-vivo modification of autologous CD34+ HSPCs using a CD11B-directed lentiviral vector encoding APOEII-tagged human IDS leads to supraphysiological enzyme activity and early biochemical correction of neuronopathic mucopolysaccharidosis type II patients

Nathan Jeffreys, Claire Horgan, Kelly Watts et al. Nov 03, 2025 pp. 384-384 10.1182/blood-2025-384

Abstract Background: Mucopolysaccharidosis type II (MPSII, Hunter Syndrome) is a rare paediatric X-linked lysosomal storage disease caused b...

Trends in Acute Myeloid Leukemia mortality among patients with diabetes mellitus in the United States, 1999–2024: A CDC wonder database analysis

Muhammad Shaheer Bin Faheem, Amar Lal, Syed Tawassul Hassan Nov 03, 2025 pp. 6911-6911 10.1182/blood-2025-6911

Abstract Abstract: INTRODUCTION: Diabetes mellitus (DM) is increasingly recognized as a comorbidity that complicates can...

NUP98 rearrangements (NUP98r) in Acute Myeloid Leukemia (AML): A genomic landscape study

Osama Batayneh, Alanna Siegenthaler, Deevyashali Parekh et al. Nov 03, 2025 pp. 5283-5283 10.1182/blood-2025-5283

Abstract Background: Nucleoporin 98 rearrangements (NUP98r) occur in a wide range of hematologic malignancies including AML and have been sh...

Trends in mortality from multiple myeloma in patients younger than 55 years of age in the United States: A retrospective analysis from 1999 to 2020

Fawad Talat, Abdul basit Khan, Rehan Ishaque et al. Nov 03, 2025 pp. 8141-8141 10.1182/blood-2025-8141

Abstract Background: Multiple myeloma is a malignancy of advanced age and is most commonly diagnosed in patients older than 65 years of age....

Harnessing repressive LEF1/β-catenin complexes to overcome drug resistance in chronic lymphocytic leukemia

Kadriye Nehir Cosgun, Takeshi Ito, Mark Robinson et al. Nov 03, 2025 pp. 5659-5659 10.1182/blood-2025-5659

Abstract Background and Significance. LEF1 is overexpressed and often used as diagnostic marker for CLL. LEF1 is a transcriptional target an...

Impact of EBV status on the characteristics and prognosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients: Long-term experience from the GELTAMO group

Daniel Gil Alós, Sofia Sánchez, Samuel Romero Dominguez et al. Nov 03, 2025 pp. 472-472 10.1182/blood-2025-472

Abstract Introduction Post-transplant lymphoproliferative disorders (PTLD) are a heterogeneous group of immunosuppression-related conditions...

Transition to fellowship: A qualitative exploration of the experience of hematology-oncology fellowship at the university of Colorado

Lisa Chu, Ashley Dafoe, Brandon McMahon et al. Nov 03, 2025 pp. 8216-8216 10.1182/blood-2025-8216

Abstract Background: The transition from internal medicine residency to fellowship is a crucial phase as physicians terminally differentiate...

primary efficacy and safety of first-line R-MTO regimen (rituximab, methotrexate, thiotepa, and orelabrutinib) followed by autologous hematopoietic stem cell transplantation in PCNSL

Haichen Wei, Xin Wang, Lijie Xing et al. Nov 03, 2025 pp. 3687-3687 10.1182/blood-2025-3687

Abstract Background: Primary central nervous system lymphoma (PCNSL) is a rare and aggressive B-cell malignancy with poor long-term survival....

Prolyl-tRNA synthetase inhibition disrupts oncogenic translation in T-cell acute lymphoblastic leukemia

Valerio Ciaurro, Abdul Khalique, Priyanshu Srivastava et al. Nov 03, 2025 pp. 6780-6780 10.1182/blood-2025-6780

Abstract T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer marked by the abnormal growth of immature thymocytes. 5-y...

Efficacy and safety analysis of letermovir for the prevention of CMV infection after haploidentical hematopoietic stem cell transplantation in children with acute leukemia

Huili Zhu, Zhijie Wei, Peihua Lu Nov 03, 2025 pp. 2440-2440 10.1182/blood-2025-2440

Abstract Introduction: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative approach for childhood acute leukemia. I...

Adapted physical activity during first line therapy in multiple myéloma : Innovative assessment of physical status during first-line therapy in 22 multiple myeloma patients

Cecile Sonntag Mottier, Joris mallard, Charline Fuseau et al. Nov 03, 2025 pp. 5752-5752 10.1182/blood-2025-5752

Abstract Background Multiple myeloma (MM) patients have been first excluded from exercise programs due to their pain and fracture risk. Howe...

Technical benchmarking of eight machine‑learning algorithms versus penalized logistic regression for predicting in‑hospital death in 117,765 u.S. CLL/SLL admissions

Xiaoyi Zhang, Abhishek Kumar, Lisha Xiao et al. Nov 03, 2025 pp. 7916-7916 10.1182/blood-2025-7916

Abstract Background Machine-learning (ML) is widely promoted for hospital risk prediction, yet its incremental value over well-specified sta...

Long-read direct RNA-seq reveals dynamic MM transcriptome made of novel isoforms and post-transcriptional modifications

Christopher Schorr, Nathan Becker, Pengyue Zhang et al. Nov 03, 2025 pp. 3915-3915 10.1182/blood-2025-3915

Abstract Background: Increasing evidence indicates considerable heterogeneity in multiple myeloma (MM) clinical course and treatment response...

Oral VP16 combined with ATRA and realgar-indigo naturalis formula as complete oral induction regimen is an fast,safe and effective regimen during induction to reduce mortality in high-risk acute promyelocytic leukemia

Wenbing Duan, Qi Chen, Wen-Jing Yu et al. Nov 03, 2025 pp. 6966-6966 10.1182/blood-2025-6966

Abstract Background: Early death in high-risk acute promyelocytic leukemia (APL) is closely related to the leukocytosis at the onset of the...

Allogeneic hematopoietic stem cell transplantation in sil::TAL1-positive T-ALL: Prognostic impact of pre-transplant remission and molecular status

Xiao-Hong Liu, Jing Long, Jiarui Zhou et al. Nov 03, 2025 pp. 2502-2502 10.1182/blood-2025-2502

Abstract Introduction The SIL::TAL1 fusion gene, caused by a 1p32 deletion, is a common molecular alteration in T-cell acute lymphoblastic l...

Comparing the accuracy of natural language processing labelling versus manual chart review and ICD-10 codes to identify bleeding events in patients with cancer

Thomas Fusillo, Avi Leader, Rohan Singh et al. Nov 03, 2025 pp. 6114-6114 10.1182/blood-2025-6114

Abstract Background: Identifying bleeding events in the electronic health record (EHR) is challenging and often requires laborious manual ch...

Comparative high-dimensional profiling reveals distinct immune reconstitution dynamics between CD19 and CD7 CAR-T therapies in acute leukemia

Xuying Pei, Zhipeng Zhou, Zhifan Zhao et al. Nov 03, 2025 pp. 4099-4099 10.1182/blood-2025-4099

Abstract Background: Chimeric antigen receptor T-cell (CAR-T) therapies targeting distinct lineage antigens such as CD19 (B-cell) or CD7 (T-...

Bridging the gap between protocol and practice: A quality improvement initiative to optimize platelet use in a community healthcare setting

Amanda Lussier, Sooraj Srirangadhamu Gopu, Jatin Thukral et al. Nov 03, 2025 pp. 4390-4390 10.1182/blood-2025-4390

Abstract Introduction: Platelet transfusion (PLT) is a critical intervention used to prevent or manage bleeding in individuals with platelet...

Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020

Manzer Ali, Kashish Magnani, Saad Rashid et al. Nov 03, 2025 pp. 8069-8069 10.1182/blood-2025-8069

Abstract Background: Chronic lymphocytic leukemia (CLL) exhibits a broad clinical spectrum, ranging from indolent lymphocytosis to aggressiv...

Nutrition needs assessment for sickle cell disease throughout the lifespan

Ariana Patel, Michell Fullmer, Stephanie Guarino Nov 03, 2025 pp. 6230-6230 10.1182/blood-2025-6230

Abstract Introduction: Patients with sickle cell disease (SCD) experience a range of debilitating symptoms, including vaso-occlusive crises...

Impact of social determinants on inpatient outcomes in hairy cell leukemia: A national cohort study

Canan Dirican, Anas Al Mardini, Amara Sofia et al. Nov 03, 2025 pp. 8037-8037 10.1182/blood-2025-8037

Abstract Background: Hairy Cell Leukemia (HCL) is a rare, indolent B-cell lymphoproliferative disorder with a generally favorable prognosis...

Impact of fatigue on health care resource utilization and costs in sickle cell disease in the United States

Jing Voon Chen, Mihail Samnaliev, Yi Pan et al. Nov 03, 2025 pp. 7977-7977 10.1182/blood-2025-7977

Abstract Introduction: Fatigue is a common symptom of sickle cell disease (SCD). However, the economic burden associated with fatigue among...

Discovering the epidemiology, treatment patterns, and outcomes of chronic lymphocytic leukemia: A retrospective multicenter cohort study

Laura Morel, Cardozo María, Rodrigo Santacruz et al. Nov 03, 2025 pp. 7431-7431 10.1182/blood-2025-7431

Abstract Introduction Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in Western countries, wit...

Rapid DNA-methylation based classification of hematological malignancies

Tristan Achterberg, Esmée de Ruijter, Marc van Tuil et al. Nov 03, 2025 pp. 119-119 10.1182/blood-2025-119

Abstract Accurate molecular classification of hematological malignancies is essential for treatment and prognosis. Current diagnostic workfl...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page